Lexeo Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Lexeo Therapeutics, Inc. (LXEO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.4% of the shares are freely tradable; institutional investors hold 115.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 7.78 | 6,384,200 | +410.7 | 06/30/2026 |
| Affinity Asset Advisors, LLC | 7.07 | 5,807,611 | +15.0 | 06/30/2026 |
| BlackRock Inc | 6.99 | 5,739,455 | +12.3 | 06/30/2026 |
| RA Capital Management, LLC | 6.09 | 5,000,000 | +0.0 | 06/30/2026 |
| HHG PLC | 6.06 | 4,976,429 | -9.7 | 03/31/2026 |
| Frazier Life Sciences Management, L.P. | 5.88 | 4,824,725 | +9.0 | 06/30/2026 |
| State Street Corp | 5.31 | 4,354,757 | +22.0 | 06/30/2026 |
| Vestal Point Capital LP | 5.26 | 4,320,000 | -3.5 | 06/30/2026 |
| Paradigm Biocapital Advisors LP | 5.09 | 4,175,382 | -32.5 | 06/30/2026 |
| Jupiter Topco LLC | 4.82 | 3,954,691 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Townsend Richard Nolan | Chief Executive Officer | 376,778 | 1,168,012 $ | Sep 14, 2026 | direct |
| Otero Jose Manuel | Chief Operating Officer | 138,288 | 428,693 $ | Sep 14, 2026 | direct |
| Tamayo Louis Edward | Chief Financial Officer | 92,907 | 288,012 $ | Aug 18, 2026 | direct |
| Bhalla Narinder Pal | Chief Medical Officer | 84,908 | 263,215 $ | Sep 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Bhalla Narinder Pal | Chief Medical Officer | Other | 2,714 | 3.58 | 9,713 |
| Sep 14, 2026 | Otero Jose Manuel | Chief Operating Officer | Other | 2,110 | 2.64 | 5,579 |
| Sep 14, 2026 | Townsend Richard Nolan | Chief Executive Officer | Other | 2,306 | 2.64 | 6,097 |
| Aug 18, 2026 | Tamayo Louis Edward | Chief Financial Officer | Sell | 4,117 | 4.91 | 20,203 |
| Aug 18, 2026 | Otero Jose Manuel | Chief Operating Officer | Sell | 1,304 | 4.96 | 6,464 |
| Aug 18, 2026 | Townsend Richard Nolan | Chief Executive Officer | Sell | 3,345 | 4.95 | 16,562 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.